NeuroBo Pharmaceuticals Announces Strategic Realignment Ahead of Important Clinical Milestones with Name Change to MetaVia - Reflecting the Company's Focus on Cardiometabolic Diseases

Stock Information for Cognition Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.